scholarly article | Q13442814 |
P356 | DOI | 10.1093/CVR/CVU113 |
P698 | PubMed publication ID | 24776597 |
P50 | author | Albert J.R. Heck | Q2865808 |
Arjan D Barendrecht | Q59158839 | ||
P2093 | author name string | Philip G de Groot | |
Mark Roest | |||
Arjen Scholten | |||
Thijs C van Holten | |||
Onno B Bleijerveld | |||
Patrick Wijten | |||
Tesy H Merkx | |||
P2860 | cites work | Cathepsin G activates protease-activated receptor-4 in human platelets | Q22253276 |
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin | Q24563384 | ||
Platelet functions beyond hemostasis | Q33385887 | ||
The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes | Q33571290 | ||
Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets | Q33715620 | ||
PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation | Q34560212 | ||
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released | Q34584213 | ||
Platelets in inflammation and atherogenesis. | Q36328825 | ||
Platelet secretion is kinetically heterogeneous in an agonist-responsive manner | Q36509648 | ||
Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet α-granules | Q46590284 | ||
High precision platelet releasate definition by quantitative reversed protein profiling--brief report | Q50335786 | ||
P433 | issue | 1 | |
P304 | page(s) | 140-146 | |
P577 | publication date | 2014-04-28 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets | |
P478 | volume | 103 |
Q36596892 | CCL5 derived from platelets increases megakaryocyte proplatelet formation |
Q89820694 | Imaging Platelet Processes and Function-Current and Emerging Approaches for Imaging in vitro and in vivo |
Q46245186 | Modification of immunological features in human platelets during sepsis. |
Q42470113 | PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate. |
Q49587121 | Plasma QconCATs reveal a gender-specific proteomic signature in apheresis platelet plasma supernatants |
Q47738050 | Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice. |
Q35126262 | Platelet hyaluronidase-2: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation. |
Q38813483 | Platelet proteomics applied to the search for novel antiplatelet therapeutic targets |
Q50897118 | Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling. |
Q38590568 | Platelet secretory behaviour: as diverse as the granules … or not? |
Q37582770 | Platelet-functionalized three-dimensional poly-ε-caprolactone fibrous scaffold prepared using centrifugal spinning for delivery of growth factors |
Q38584175 | Platelets in cancer metastasis: To help the "villain" to do evil |
Q38543311 | Proteomic signatures of antiplatelet drugs: new approaches to exploring drug effects. |
Q36131991 | Respective contributions of single and compound granule fusion to secretion by activated platelets. |
Q38785881 | Taking the stock of granule cargo: Platelet releasate proteomics |
Q27004467 | The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors |
Q52719266 | The Platelet Lifeline to Cancer: Challenges and Opportunities. |
Q39051769 | The cellular basis of platelet secretion: Emerging structure/function relationships |
Q38790876 | The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays. |
Q52645832 | The life cycle of platelet granules. |
Q33733964 | The nuts and bolts of the platelet release reaction |
Q36128546 | Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity |
Search more.